Michael Gelband’s Pediatrix Medical MD Stock Holding History

Michael Gelband’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-35,294	Closed	-$591K	–	1846
2025 Q3	$591K	Buy	35,294 +11,411	+48%	+$171K	0.01%	1133
2025 Q2	$343K	Buy	+23,883	New	+$328K	﹤0.01%	1222
2024 Q3	–	Sell	-69,928	Closed	-$528K	–	1895
2024 Q2	$528K	Buy	+69,928	New	+$578K	﹤0.01%	1204
2024 Q1	–	Sell	-119,540	Closed	-$1.11M	–	1779
2023 Q4	$1.11M	Sell	119,540 -129,325	-52%	-$1.34M	0.01%	781
2023 Q3	$3.16M	Buy	248,865 +44,731	+22%	+$614K	0.03%	510
2023 Q2	$2.9M	Sell	204,134 -75,241	-27%	-$1.06M	0.02%	660
2023 Q1	$4.17M	Buy	279,375 +189,124	+210%	+$2.87M	0.03%	580
2022 Q4	$1.34M	Buy	90,251 +41,683	+86%	+$680K	0.02%	823
2022 Q3	$802K	Buy	48,568 +4,695	+11%	+$94.5K	0.01%	1195
2022 Q2	$922K	Sell	43,873 -12,254	-22%	-$250K	0.01%	1122
2022 Q1	$1.32M	Buy	+56,127	New	+$1.37M	0.02%	985
2021 Q4	–	Sell	-23,637	Closed	-$672K	–	2432
2021 Q3	$672K	Buy	23,637 +7,705	+48%	+$235K	0.01%	1237
2021 Q2	$480K	Buy	+15,932	New	+$470K	0.01%	1468
2020 Q2	–	Sell	-38,758	Closed	-$451K	–	1917
2020 Q1	$451K	Buy	38,758 +29,642	+325%	+$611K	0.02%	523
2019 Q4	$253K	Buy	+9,116	New	+$229K	﹤0.01%	1234
2019 Q3	–	Sell	-8,500	Closed	-$214K	–	1515
2019 Q2	$214K	Buy	+8,500	New	+$228K	0.01%	891

Other funds holding MD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Michael Gelband's MD Position: Q4 2025 in Review

Michael Gelband sold out of Pediatrix Medical (MD) in Q4 2025, closing a stake of 35,294 shares — an estimated $591K sold.

Michael Gelband first reported a position in MD in Q2 2019 and held it in 16 quarters. The position peaked at $4.17M in Q1 2023. 299 funds tracked by Wall St. Rank hold MD as of Q4 2025.

Michael Gelband reported no remaining Pediatrix Medical position as of Q4 2025 after selling out during the quarter.
Michael Gelband sold 35,294 Pediatrix Medical shares in Q4 2025, an estimated $591K.
Michael Gelband first reported a position in Pediatrix Medical in Q2 2019 and held it in 16 quarters.
Michael Gelband's Pediatrix Medical position peaked at $4.17M in Q1 2023.
299 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2025.

Based on ExodusPoint Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.